C4 Therapeutics, Inc. (CCCC)
3.53
-0.06
(-1.67%)
USD |
NASDAQ |
Jun 09, 15:40
C4 Therapeutics Profit Margin (Quarterly) : -408.5% for March 31, 2026
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Cartesian Therapeutics, Inc. | -50.23K% |
| Arrowhead Pharmaceuticals, Inc. | -186.6% |
| Oncolytics Biotech, Inc. | -- |
| Sangamo Therapeutics, Inc. | -2.15K% |
| Sarepta Therapeutics, Inc. | 45.29% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -51.16% |
| Return on Assets | -32.80% |
| Return on Invested Capital | -39.27% |
| Gross Profit Margin (Quarterly) | 70.72% |
| Operating Margin (Quarterly) | -451.6% |
| Return on Net Operating Assets | -186.0% |